The PI3K/AKT signaling pathway regulates a large number of cellular processes, such as the cell cycle, proliferation, differentiation and apoptosis [5,7,45], whose dysregulation in leukemia stem cells (LSCs) increases ROS production and promotes the survival of LSCs and their drug resistance [6]. The gene discussed is AKT1; the disease is leukemia.